drugset / Trial / NCT04897984

LEAP2 Kinetics in Healthy Individuals

NCT04897984 ↗

Phase 0 Completed 8 enrolled University Hospital, Gentofte, Copenhagen
NaSingle-groupOpen-labelTreatment

Summary

The study aims to investigate the kinetics of the naturally occurring peptide liver-enriched antimicrobial peptide 2 (LEAP-2) in healthy volunteers. The overall objective is to investigate the physiological importance of LEAP-2 in healthy subjects.

Timeline

Start
2021-05-24
Primary completion
2021-06-25
Completion
2021-06-25

Drugs

EvaluationDrugModalityDoseRoute
Subject LEAP2 Peptide — Intravenous

Indications